Verrica is a dermatology therapeutics company developing medications for skin diseases requiring medical interventions. Verrica's late-stage product candidate, VP-102, is in development to treat molluscum, common warts and external genital warts, three of the largest unmet needs in medical dermatology. Verrica is also developing VP-103, its second cantharidin-based product candidate, for the treatment of plantar warts. The Company has also entered a worldwide license agreement with Lytix Biopharma AS to develop and commercialize LTX-315 for dermatologic oncology conditions.
View Top Employees from Verrica Pharmaceuticals Inc.Website | http://www.verrica.com |
Ticker | VRCA |
Employees | View employees |
Founded | 2013 |
Address | 44 W Gay St, Ste 400, West Chester, Pennsylvania 19380, US |
Phone | (484) 453-3300 |
Industry | Drug Manufacturing & Research, Health Care, Pharmaceuticals, Medical, Healthcare, Pharmaceutical |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies |
Looking for a particular Verrica Pharmaceuticals Inc. employee's phone or email?
Verrica Pharmaceuticals Inc. is based in West Chester, Pennsylvania.
The NAICS codes for Verrica Pharmaceuticals Inc. are [3254, 325, 32, 32541].
The SIC codes for Verrica Pharmaceuticals Inc. are [28, 283].